Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: A national cohort study

Journal of Clinical Oncology

Volumn 30, Issue 22, 2012, Pages 2745-2752

  Swerdlow, Anthony J ^o   Cooke, Rosie ^o   Bates, Andrew ^b   Cunningham, David ^a   Falk, Stephen J ^c   Gilson, Dianne ^d   Hancock, Barry W ^e   Harris, Sarah J ^f   Horwich, Alan ^o   Hoskin, Peter J ⁱ   Linch, David C ^g   Lister, T Andrew ^h   Lucraft, Helen H ^j   Radford, John A ^k   Stevens, Andrea M ^l   Syndikus, Isabel ^m   Williams, Michael V ⁿ  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

^d St James's Institute of Oncology   (United Kingdom)

^e WESTON PARK HOSPITAL   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^h ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

ⁱ MOUNT VERNON HOSPITAL   (United Kingdom)

^j FREEMAN HOSPITAL   (United Kingdom)

^k UNIVERSITY OF MANCHESTER   (United Kingdom)

^l QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^m CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

ⁿ ADDENBROOKE S HOSPITAL   (United Kingdom)

^o INSTITUTE OF CANCER RESEARCH   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ALKYLATING CHEMOTHERAPY; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE FACTORS; BREAST NEOPLASMS; COHORT STUDIES; DIAPHRAGM; ENGLAND; HODGKIN DISEASE; HUMANS; NEOPLASMS, RADIATION-INDUCED; RADIOTHERAPY DOSAGE; RISK; WALES;

EID: 84864568347     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.38.8835     Document Type: Article

References (37)

1. Aisenberg AC, Finkelstein DM, Doppke KP, et al: High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer 79:1203-1210, 1997 (Pubitemid 27118218)
2. Hancock SL, Tucker MA, Hoppe RT: Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 85:25-31, 1993 (Pubitemid 23023219)
3. Mauch PM, Kalish LA, Marcus KC, et al: Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: Long-term analysis of risk factors and outcome. Blood 87:3625-3632, 1996 (Pubitemid 26129590)
4. Bhatia S, Robison LL, Oberlin O, et al: Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334:745-751, 1996 (Pubitemid 26089355)
5. O'Brien MM, Donaldson SS, Balise RR, et al: Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy. J Clin Oncol 28:1232-1239, 2010
6. Sankila R, Garwicz S, Olsen JH, et al: Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five Nordic countries. J Clin Oncol 14:1442-1446, 1996 (Pubitemid 26134199)
7. Swerdlow AJ, Barber JA, Hudson GV, et al: Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment. J Clin Oncol 18:498-509, 2000 (Pubitemid 30078531)
8. Taylor AJ, Winter DL, Stiller CA, et al: Risk of breast cancer in female survivors of childhood Hodgkin's disease in Britain: A population-based study. Int J Cancer 120:384-391, 2007 (Pubitemid 44956851)
9. De Bruin ML, Sparidans J, van't Veer MB, et al: Breast cancer risk in female survivors of Hodgkin's lymphoma: Lower risk after smaller radiation volumes. J Clin Oncol 27:4239-4246, 2009
10. Ng AK, Bernardo MVP, Weller E, et al: Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: Long-term risks and risk factors. Blood 100:1989-1996, 2002 (Pubitemid 35001228)
11. Bhatia S, Yasui Y, Robison LL, et al: High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the Late Effects Study Group. J Clin Oncol 21:4386-4394, 2003 (Pubitemid 46621816)
12. Kenney LB, Yasui Y, Inskip PD, et al: Breast cancer after childhood cancer: A report from the Childhood Cancer Survivor Study. Ann Intern Med 141:590-597, 2004 (Pubitemid 39390536)
13. Green DM, Hyland A, Barcos MP, et al: Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence. J Clin Oncol 18:1492-1499, 2000 (Pubitemid 30205395)
14. Donaldson SS, Hancock SL: Second cancers after Hodgkin's disease in childhood. N Engl J Med 334:792-794, 1996 (Pubitemid 26089364)
15. Metayer C, Lynch CF, Clarke EA, et al: Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 18:2435-2443, 2000 (Pubitemid 30415831)
16. Ronckers CM, Erdmann CA, Land CE: Radiation and breast cancer: A review of current evidence. Breast Cancer Res 7:21-32, 2005 (Pubitemid 40214533)
17. Morris DH, Jones ME, Schoemaker MJ, et al: Determinants of age at menarche in the UK: Analyses from the Breakthrough Generations Study. Br J Cancer 103:1760-1764, 2010
18. Marshall WA, Tanner JM: Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291-303, 1969
19. Carel JC, Léger J: Clinical practice. Precocious puberty. N Engl J Med 358:2366-2377, 2008
20. Dores GM, Metayer C, Curtis RE, et al: Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years. J Clin Oncol 20:3484-3494, 2002
21. National Research Council Committee on the Biological Effects of Ionizing Radiations: Health Effects of Exposure to Low Levels of Ionizing Radiation. Washington, DC, National Academies Press, 1990
22. Boice JD Jr, Preston D, Davis FG, et al: Frequent chest x-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res 125:214-222, 1991
23. Preston DL, Mattsson A, Holmberg E, et al: Radiation effects on breast cancer risk: A pooled analysis of eight cohorts. Radiat Res 158:220-235, 2002 (Pubitemid 34851818)
24. Tinger A, Wasserman TH, Klein EE, et al: The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique. Int J Radiat Oncol Biol Phys 37:865-870, 1997 (Pubitemid 27181320)
25. van Leeuwen FE, Klokman WJ, Stovall M, et al: Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 95:971-980, 2003 (Pubitemid 36896714)
26. Travis LB, Hill DA, Dores GM, et al: Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 290:465-475, 2003 (Pubitemid 37430500)
27. Inskip PD, Robison LL, Stovall M, et al: Radiation dose and breast cancer risk in the childhood cancer survivor study. J Clin Oncol 27:3901-3907, 2009
28. De Bruin ML, Huisbrink J, Hauptmann M, et al: Treatment-related risk factors for premature menopause following Hodgkin lymphoma. Blood 111:101-108, 2008
29. Basu SK, Schwartz C, Fisher SG, et al: Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease. Int J Radiat Oncol Biol Phys 72:34-40, 2008
30. Sklar C: Maintenance of ovarian function and risk of premature menopause related to cancer treatment. J Natl Cancer Inst Monogr 34:25-27, 2005
31. Travis LB, Hill D, Dores GM, et al: Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst 97:1428-1437, 2005 (Pubitemid 41520078)
32. Easton DF, Ford D, Bishop DT: Breast and ovarian cancer incidence in BRCA1-mutation carriers: Breast Cancer Linkage Consortium. Am J Hum Genet 56:265-271, 1995
33. Hopper JL, Southey MC, Dite GS, et al: Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2: Australian Breast Cancer Family Study. Cancer Epidemiol Biomarkers Prev 8:741-747, 1999 (Pubitemid 29445010)
34. King MC, Marks JH, Mandell JB: Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643-646, 2003 (Pubitemid 37310920)
35. Ralleigh G, Given-Wilson R: Breast cancer risk and possible screening strategies for young women following supradiaphragmatic irradiation for Hodgkin's disease. Clin Radiol 59:647-650, 2004 (Pubitemid 39022762)
36. Leach MO, Boggis CR, Dixon AK, et al: Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: A prospective multicenter cohort study (MARIBS). Lancet 365:1769-1778, 2005 (Pubitemid 40744657)
37. Saslow D, Boetes C, Burke W, et al: American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75-89, 2007 (Pubitemid 46535708)